No. | Publication Date | Citing Article |
---|---|---|
1 | 2025 | Joanna Dunacka, Beata Grembecka, Irena Majkutewicz, Danuta Wrona. Central Insulin-like Growth Factor-1 Treatment Enhances Working and Reference Memory by Reducing Neuroinflammation and Amyloid Beta Deposition in a Rat Model of Sporadic Alzheimer’s Disease, Pharmaceuticals. 2025; 18: 527. https://doi.org/10.3390/ph18040527 |
2 | 2025 | Jonathan Zegarra-Valdivia, Harold Arana-Nombera, Leandro Perez-Fernandez, Milagros del Rocío Casimiro, Viviana Gallegos-Manayay, María del Rosario Oliva-Piscoya, Reyna Alamo-Medina, Eduardo Abanto-Saldaña, María Celinda Cruz-Ordinola, Carmen Paredes-Manrique, Brenda Chino-Vilca. Insulin-like Growth Factor 1 Impact on Alzheimer’s Disease: Role in Inflammation, Stress, and Cognition, Current Issues in Molecular Biology. 2025; 47: 233. https://doi.org/10.3390/cimb47040233 |
3 | 2025 | Navpreet Kaur, Khadga Raj Aran. Uncovering the intricacies of IGF-1 in Alzheimer’s disease: new insights from regulation to therapeutic targeting, Inflammopharmacology. 2025; 33: 1311. https://doi.org/10.1007/s10787-025-01641-0 |